146 related articles for article (PubMed ID: 34647332)
1. LINC00662: A new oncogenic lncRNA with great potential.
Zhong C; Zhang Q; Zhang M; Qi Y; Duan S
J Cell Physiol; 2022 Feb; 237(2):1105-1118. PubMed ID: 34647332
[TBL] [Abstract][Full Text] [Related]
2. LINC00662 promotes hepatocellular carcinoma progression via altering genomic methylation profiles.
Guo T; Gong C; Wu P; Battaglia-Hsu SF; Feng J; Liu P; Wang H; Guo D; Yao Y; Chen B; Xiao Y; Liu Z; Li Z
Cell Death Differ; 2020 Jul; 27(7):2191-2205. PubMed ID: 31959915
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D
Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J
Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128
[TBL] [Abstract][Full Text] [Related]
5. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
6. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
7. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
8. MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma.
Wang Y; Li W; Chen X; Li Y; Wen P; Xu F
Biomed Pharmacother; 2019 Mar; 111():1297-1301. PubMed ID: 30841443
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Peng W; Fan H
Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells.
Guo JC; Yang YJ; Zheng JF; Zhang JQ; Guo M; Yang X; Jiang XL; Xiang L; Li Y; Ping H; Zhuo L
Exp Mol Med; 2019 Nov; 51(11):1-20. PubMed ID: 31757938
[TBL] [Abstract][Full Text] [Related]
14. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.
Sun L; Wang L; Chen T; Shi Y; Yao B; Liu Z; Wang Y; Li Q; Liu R; Niu Y; Tu K; Liu Q
Cell Death Dis; 2020 Feb; 11(2):95. PubMed ID: 32024815
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells Promote Hepatocarcinogenesis via lncRNA-MUF Interaction with ANXA2 and miR-34a.
Yan X; Zhang D; Wu W; Wu S; Qian J; Hao Y; Yan F; Zhu P; Wu J; Huang G; Huang Y; Luo J; Liu X; Liu B; Chen X; Du Y; Chen R; Fan Z
Cancer Res; 2017 Dec; 77(23):6704-6716. PubMed ID: 28947421
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
17. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway.
Zhang W; Wu Y; Hou B; Wang Y; Deng D; Fu Z; Xu Z
Mol Oncol; 2019 Oct; 13(10):2194-2210. PubMed ID: 31402556
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
[TBL] [Abstract][Full Text] [Related]
19. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CCAL promotes hepatocellular carcinoma progression by regulating AP-2α and Wnt/β-catenin pathway.
Liu Y; Yang Y; Wang T; Wang L; Wang X; Li T; Shi Y; Wang Y
Int J Biol Macromol; 2018 Apr; 109():424-434. PubMed ID: 29275200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]